Related Experiment Video
Updated: Jul 7, 2026
09:31
Assessing Replication and Beta Cell Function in Adenovirally-transduced Isolated Rodent Islets
Published on: June 25, 2012
[Insulin resistance and beta 3-adrenergic receptor function]
I Kobayashi1, T Ishigami, S Umemura
1Second Department of Internal Medicine, Yokohama City University School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 9, 2000
Summary
Beta 3-adrenergic receptors regulate fat breakdown and energy expenditure. A specific gene mutation is linked to obesity and type 2 diabetes, though its precise role in insulin resistance requires further investigation.
Area of Science:
- Adrenergic Receptor Signaling
- Metabolic Regulation
- Obesity and Diabetes Research
Context:
- Beta 3-adrenergic receptors (ADRB3) are primarily found on white and brown adipocytes.
- ADRB3 activation promotes lipolysis and thermogenesis, influencing energy expenditure.
- ADRB3 dysfunction is hypothesized to contribute to obesity and insulin resistance.
Purpose:
- To explore the association between beta 3-adrenergic receptor function and metabolic disorders.
- To investigate the prevalence and implications of the Trp64Arg ADRB3 gene mutation.
- To clarify the detailed role of ADRB3 in the development of insulin resistance.
Summary:
- The Trp64Arg mutation in the beta 3-adrenergic receptor gene is common in certain populations and linked to obesity and early-onset type 2 diabetes.
- Despite minimal acute functional impact, this mutation's association with metabolic diseases warrants further study.
- The precise mechanisms by which beta 3-adrenergic receptors influence insulin resistance remain incompletely understood.
Impact:
- Understanding ADRB3's role could reveal novel therapeutic targets for obesity and type 2 diabetes.
- Genetic screening for ADRB3 mutations may aid in identifying individuals at higher risk.
- Further research is crucial for translating these findings into clinical applications for metabolic disease management.
Related Concept Videos
01:27Adrenergic Receptors (Adrenoceptors): Classification
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:31Sympathetic Signaling
Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.